Primary graft dysfunction (PGD) remains the leading cause of early mortality post-heart
transplantation. Despite improvements in mechanical circulatory support and critical care …

The field of heart transplantation continues to evolve, with major changes in allocation
systems and the increasing use of extended-criteria donor hearts, including hearts from …

This 36th adult lung and heart-lung transplant report summarizes data from 69,200 adult
lung and 4,128 adult heart-lung transplants performed through June 30, 2018 and reported …

Although primary graft dysfunction (PGD) is fairly common early after cardiac transplant,
standardized schemes for diagnosis and treatment remain contentious. Most major cardiac …

Heart transplantation is currently the definitive gold standard surgical approach in the
treatment of refractory heart failure. However, the shortage of donors limits the achievement …

Prezados colegas, Grandes avanços no diagnóstico, monitorização e tratamento da
Insuficiência Cardíaca (IC) foram observados nos últimos anos, com impactos reais na …

Changes in heart transplantation (HT) donor and recipient demographics may influence the
incidence of primary graft dysfunction (PGD). We conducted a retrospective study to …

The shortage of donors in cardiac transplantation may be alleviated by the use of allografts
from donation after circulatory death (DCD) donors. We have previously shown that hearts …

Background Free radical production and mitochondrial dysfunction during cardiac graft
reperfusion is a major factor in post-transplant ischemia-reperfusion (IR) injury, an important …

Objective Venoarterial extracorporeal membrane oxygenation is a useful treatment for
severe primary graft dysfunction after heart transplant. The ideal timing of initiation is …